Axon Lab Becomes New iSOFT Distribution Partner in Switzerland

iSOFTAxon Lab AG, a leading service provider for diagnostics and molecular biology, will support iSOFT, an IBA Health Group company, as distribution partner in Switzerland with immediate effect. Core elements of the agreement are the distribution, implementation and support of the leading iSOFT laboratory solution, LabCentre. iSOFT is the market leader in laboratory information systems with more than 200 installations in Germany. LabCentre is a full-graphic integrated system, covering clinical laboratory, blood donation and microbiology. With the laboratory info center (l.i.c), LabCentre includes integrated communication functions for order processing and reporting, and supports decentralised point-of-care testing.

Gary Cohen, Executive Chairman and CEO of IBA Health Group, stressed the leading role of iSOFT in Europe: "Our agreement with Axon Lab continues our expansion in Europe. At present we rank among the leading suppliers of e-health solutions in the UK, Germany, the Netherlands and Spain. Further markets in Europe will follow soon."

Axon Lab AG has been a dedicated service provider in the fields of diagnostics and molecular biology since 1989. The company installs and supports a range of diagnostic equipment and software applications.

Related news articles:

About iSOFT
Following a merger completed on Tuesday 30 October, iSOFT is now part of the IBA Health Group. For further information, please visit http://www.ibahealth.com.

iSOFT products are used by more than 8,000 organisations in 27 countries for managing patient information and driving improvements in healthcare services. For further information, please visit http://www.isoftplc.com.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...